Phong Phu Pharmaceutical JSC (HNX: PPP)
16,600
-100 (-0.60%)
At close: Jan 24, 2025
HNX:PPP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 8,876 | 8,482 | 10,301 | 12,118 | 9,009 | Upgrade
|
Short-Term Investments | 31,108 | 23,563 | 16,000 | 6,000 | - | Upgrade
|
Cash & Short-Term Investments | 39,984 | 32,044 | 26,301 | 18,118 | 9,009 | Upgrade
|
Cash Growth | 24.78% | 21.84% | 45.16% | 101.10% | -35.63% | Upgrade
|
Accounts Receivable | 11,094 | 13,188 | 13,568 | 10,446 | 10,133 | Upgrade
|
Other Receivables | 896.66 | 1,392 | 612.57 | 321.78 | 468.97 | Upgrade
|
Receivables | 11,991 | 14,580 | 14,181 | 10,768 | 10,602 | Upgrade
|
Inventory | 36,899 | 32,000 | 36,759 | 41,533 | 34,712 | Upgrade
|
Prepaid Expenses | 387.27 | 241.55 | 157.02 | 192.73 | 281.06 | Upgrade
|
Other Current Assets | 1,967 | 778.61 | 1,074 | 163.62 | 281.03 | Upgrade
|
Total Current Assets | 91,228 | 79,644 | 78,472 | 70,775 | 54,885 | Upgrade
|
Property, Plant & Equipment | 57,498 | 60,464 | 60,239 | 64,374 | 68,777 | Upgrade
|
Other Intangible Assets | 16,851 | 17,548 | 18,244 | 18,941 | 19,638 | Upgrade
|
Long-Term Deferred Tax Assets | 468.27 | 330.04 | 474.71 | 587.83 | 357.41 | Upgrade
|
Other Long-Term Assets | 1,097 | 2,036 | 763.99 | 1,352 | 995.67 | Upgrade
|
Total Assets | 167,142 | 160,022 | 158,194 | 156,030 | 144,653 | Upgrade
|
Accounts Payable | 13,502 | 11,688 | 12,642 | 16,378 | 14,236 | Upgrade
|
Accrued Expenses | 10,357 | 10,740 | 9,175 | 7,455 | 4,923 | Upgrade
|
Short-Term Debt | - | - | - | 2,000 | 5,436 | Upgrade
|
Current Income Taxes Payable | 1,680 | 1,571 | 2,261 | 896.66 | 801.76 | Upgrade
|
Other Current Liabilities | 6,028 | 5,411 | 9,275 | 12,492 | 5,711 | Upgrade
|
Total Current Liabilities | 31,567 | 29,410 | 33,354 | 39,222 | 31,108 | Upgrade
|
Long-Term Debt | - | - | - | - | 5,665 | Upgrade
|
Other Long-Term Liabilities | 217 | 225 | 225 | 225 | 233 | Upgrade
|
Total Liabilities | 31,784 | 29,635 | 33,579 | 39,447 | 37,007 | Upgrade
|
Common Stock | 88,000 | 88,000 | 88,000 | 88,000 | 88,000 | Upgrade
|
Additional Paid-In Capital | 2,206 | 2,206 | 2,206 | 2,206 | 2,206 | Upgrade
|
Retained Earnings | 45,152 | 40,181 | 34,410 | 26,378 | 17,441 | Upgrade
|
Shareholders' Equity | 135,358 | 130,387 | 124,616 | 116,583 | 107,646 | Upgrade
|
Total Liabilities & Equity | 167,142 | 160,022 | 158,194 | 156,030 | 144,653 | Upgrade
|
Total Debt | - | - | - | 2,000 | 11,102 | Upgrade
|
Net Cash (Debt) | 39,984 | 32,044 | 26,301 | 16,118 | -2,092 | Upgrade
|
Net Cash Growth | 24.78% | 21.84% | 63.17% | - | - | Upgrade
|
Net Cash Per Share | 4067.80 | 3285.66 | 2694.95 | 1645.87 | -212.11 | Upgrade
|
Filing Date Shares Outstanding | 8.8 | 9.75 | 8.8 | 9.76 | 8.8 | Upgrade
|
Total Common Shares Outstanding | 8.8 | 9.75 | 8.8 | 9.76 | 8.8 | Upgrade
|
Working Capital | 59,660 | 50,234 | 45,119 | 31,554 | 23,777 | Upgrade
|
Book Value Per Share | 15381.59 | 13369.13 | 14160.89 | 11943.46 | 12232.55 | Upgrade
|
Tangible Book Value | 118,507 | 112,839 | 106,371 | 97,642 | 88,009 | Upgrade
|
Tangible Book Value Per Share | 13466.70 | 11569.89 | 12087.67 | 10003.03 | 10001.00 | Upgrade
|
Construction In Progress | 61.78 | - | 575.07 | - | 71.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.